Merck & Co. presents preliminary safety and PK data for islatravir in HIV-1 pre-exposure prophylaxis Jan. 28, 2021 No Comments
European Commission approves cabotegravir and rilpivirine long-acting injectable for HIV Dec. 22, 2020 No Comments
RSS